It's not often you hear that driving fast can make your car perform better, but that's essentially what many car owners believed was the solution back in the day, a practice known as the Italian ...
Broadway giant Tommy Tune's East Side apartment, with a massive terrace, is back -- with a price cut. Tim Waltman/Evan Joseph Studios Broadway giant Tommy Tune has lowered the price of his Manhattan ...
At New York’s Juilliard School of Music on Saturday, Paul Simon returned to the stage for the first time since his summer “Quiet Celebration” tour ended. While his appearance was unannounced until he ...
At least for now, the Cardinals are keeping just two quarterbacks on their roster. Arizona announced 12 roster cuts on Monday, with third-string quarterback Clayton Tune among those being waived. Tune ...
There are countless camper and RV designs out there, but if there's one that has proven itself time and time again as an affordable and versatile option for getting out there today, it's the truck ...
After the introspection of recent records, Merrill Garbus and Nate Brenner’s sixth LP sounds refreshingly unburdened, with a newfound focus on jubilant vocals and danceable beats. Save this story Save ...
If this terrace were a theater, the city would be its stage. Tommy Tune, the famed 10-time Tony Award-winning choreographer, performer and director, has relisted his Manhattan penthouse for $2.9 ...
NEW YORK--(BUSINESS WIRE)--Academy Award-winning filmmaker Errol Morris (The Fog of War, The Thin Blue Line) turns his lens to an unlikely cast of upstarts who transformed the investment landscape in ...
Tune Therapeutics, a Durham biotechnology startup co-founded by a Duke professor, announced the completion of its Series B fundraising round on Jan. 12, in which it raised $175 million to support ...
Vishal Mishra is an Indian music composer, singer, and songwriter who works primarily in Hindi cinema (Bollywood). He started his career in the music industry in the mid-2010s and has since created ...
Investors clearly appreciate the song Tune Therapeutics is singing, handing over $175 million in series B funds as the biotech takes its epigenetic silencing drug into the clinic. The funding has been ...
Tune Therapeutics’ co-founders, from left: Akira Matsuno, chief financial officer; Charles Gersbach; and Fyodor Urnov, who also serves on the startup’s scientific advisory board. (Tune Photos) Tune ...